| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Neuronetics, Inc. | Director | Common Stock | 138,563 | $437,859 | $3.16 | 25 May 2023 | Direct |
| Neuronetics, Inc. | Director | Stock Options (right to buy) | 16,102 | 25 May 2023 | Direct | ||
| CONCERT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $8.33 | 06 Mar 2023 | Direct | |
| CONCERT PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 0 | 06 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| STIM | Neuronetics, Inc. | 25 May 2023 | 1 | $0 | 4 | Director | 30 May 2023, 21:04 |
| CNCE | CONCERT PHARMACEUTICALS, INC. | 06 Mar 2023 | 9 | $0 | 4 | Director | 06 Mar 2023, 10:39 |
| CNCE | CONCERT PHARMACEUTICALS, INC. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:16 |
| STIM | Neuronetics, Inc. | 26 May 2022 | 1 | $0 | 4 | Director | 31 May 2022, 16:28 |
| CNCE | CONCERT PHARMACEUTICALS, INC. | 10 Jun 2021 | 2 | $0 | 4 | Director | 11 Jun 2021, 08:43 |
| STIM | Neuronetics, Inc. | 27 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 18:27 |